RCAT has a small analyst following relative to larger defense primes, but those who do cover the name generally frame it as a high-risk, high-reward play on secure U.S. and allied drone demand. Consensus ratings tilt toward “buy” or “speculative buy” in many summaries, with target prices that imply substantial upside from depressed levels – but also embed assumptions about revenue ramp and contract wins that are far from guaranteed.